Obstructive sleep apnea will be discussed as a significant issue in the chronic kidney disease population. Prevalence, screening techniques, effects on the disease process, treatment options, and compliance will be covered.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 9/18/2026.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
Christine Corbett, PCORI, Co-Investigator

Speaker Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

As a designated Approved Provider by the American Board for Transplant Certification (ABTC), American Nephrology Nurses Association (ANNA) grants Category 1 Continuing Education Points for Transplant certifications (CEPTC) for this offering. Approval #20004.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.

ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the participant will be able to recognize the signs/symptoms of obstructive sleep apnea (OSA)and the impact OSA can have on the progression of chronic kidney disease (CKD).

Beverly Storck MSN, RN

Appearances